DESIGN OF LIPOXIN A(4) STABLE ANALOGS THAT BLOCK TRANSMIGRATION AND ADHESION OF HUMAN NEUTROPHILS
DESIGN OF LIPOXIN A(4) STABLE ANALOGS THAT BLOCK TRANSMIGRATION AND ADHESION OF HUMAN NEUTROPHILS
复制标题
DOI:
10.1021/bi00044a041
复制
发表时间:
1995-11-07
期刊:
影响因子:
2.9
通讯作者:
MADARA, JL
中科院分区:
文献类型:
--
作者:
SERHAN, CN;MADDOX, JF;MADARA, JL
Lipoxins (LX) are bioactive eicosanoids that carry a tetraene structure and serve as regulators of inflammation, in part by inhibiting neutrophil migration and adhesion. Lipoxin A(4) is rapidly regulated by conversion to inactive LX metabolites via local metabolism that involves dehydrogenation as the predominant route. Here, several LXA(4) analogs were designed that resisted rapid conversion by both differentiated HL-60 cells and recombinant 15-hydroxyprostaglandin dehydrogenase, systems where native LXA(4) is degraded within minutes. The rank order of conversion by recombinant dehydrogenase was LXA(4) methyl ester > PGE(2) approximate to PGE(2) methyl ester > LXA(4) >>> the novel LXA(4) analogs. In addition, 15(R/S)-methyl-LXA(4), 15-cyclohexyl-LXA(A), and 16-phenoxy-LXA(4) proved to retain LXA(4) bioactivity and inhibited neutrophil transmigration across polarized epithelial cell monolayers as well as adhesion to vascular endothelial cells. These results indicate that LXA(4) analogs can be designed using these criteria to resist rapid transformation and to retain biological actions of native LXA(4). Moreover, the results suggest that LXA(4) stable analogs can be useful tools both in vitro and in vivo to evaluate LXA(4) actions and therapeutic potential.